is symlin a glp-1 glp 1 Medicare coverage changing in 2026. Starting July 1, 2026 New Molecules and Emerging Indications

Similar to GLP-1, amylin is a hormone that helps regulate energy consumption by signaling to the brain that the body is full and does not need to eat more, leading to reduced meal size and food intake, according to Wayne Ho, MD, a clinical investigator in diabetes and obesity and a professor at Keck School of Medicine in Los Angeles

GLP-1 medications slow down digestion and can lead to feelings of fullness

This expanding science reinforces that GLP-1 medications arent just a fad they may be a foundational shift in treating chronic metabolic conditions

Based on this possibility, Al-Aly and his colleagues investigated whether GLP-1 medications might affect substance use disorders more broadly

Severe cases may cause fainting (syncope), which requires immediate medical evaluation